A Phase 1b Platform, Interventional Biomarker Study of Targeted Add-on Advanced
Therapies for the Treatment of Adult Subjects with Moderate-to-Severely Active Ulcerative Colitis (LIBRA) M26-359
Principal Investigator
Dr Alissa Walsh
Contact us
Email: emcrf@ouh.nhs.uk
IRAS number
1014448